Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
18
0
2

Year Published

2011
2011
2021
2021

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 25 publications
(20 citation statements)
references
References 27 publications
0
18
0
2
Order By: Relevance
“…1 Indeed, some reports have demonstrated that lymphocyte DPPIV expression is decreased in pathological conditions in which the serum DPPIV activity is elevated. 17,33 Currently, one can only speculate that the sheddase that releases DPPIV from the cell surface to the blood stream is upregulated in HF as well as in other cardiovascular and metabolic diseases in which the serum DPPIV activity is higher than in healthy subjects. healthy subjects with no prior history of HF or cardiovascular disease were selected as controls.…”
Section: Discussionmentioning
confidence: 99%
“…1 Indeed, some reports have demonstrated that lymphocyte DPPIV expression is decreased in pathological conditions in which the serum DPPIV activity is elevated. 17,33 Currently, one can only speculate that the sheddase that releases DPPIV from the cell surface to the blood stream is upregulated in HF as well as in other cardiovascular and metabolic diseases in which the serum DPPIV activity is higher than in healthy subjects. healthy subjects with no prior history of HF or cardiovascular disease were selected as controls.…”
Section: Discussionmentioning
confidence: 99%
“…Медицинская Иммунология нонуклеаров (r = -0,48, p = 0,04) может свиде-тельствовать о возможности происхождения растворимой формы эктопептидазы вследствие секреции из мононуклеаров, так как появление растворимой формы CD26 может быть частич-но связано с протеолитическим расщеплением и/или секрецией клеточной CD26 [8].…”
Section: дьякова ме и др Medical Immunology (Russia)/meditsinskayaunclassified
“…The activity of DPPIV in a patient's serum was determined by the direct photometric method adapted to 96-well microtiter plates and according to the procedure described by Jarmołowska et al [18], but modified to some extent [17,19]. We added 50 μL of 0.3 M Gly/NaOH buffer (pH 8.7), 20 μL of 1.5 mM Gly-Pro-p-nitroanilide p-toluensulfonate (DPPIV substrate; Sigma G2901) and 50 μL of distilled water to serum samples and their blanks.…”
Section: Dppiv Activity In Serummentioning
confidence: 99%